WO2019108049A3 - Composition anticancéreuse, antibactérienne de dégradation d'alcool, de cicatrisation de plaie cutanée, de régénération cutanée ou anti-asthmatique comprenant un mélange d'ions minéraux - Google Patents

Composition anticancéreuse, antibactérienne de dégradation d'alcool, de cicatrisation de plaie cutanée, de régénération cutanée ou anti-asthmatique comprenant un mélange d'ions minéraux Download PDF

Info

Publication number
WO2019108049A3
WO2019108049A3 PCT/KR2018/015205 KR2018015205W WO2019108049A3 WO 2019108049 A3 WO2019108049 A3 WO 2019108049A3 KR 2018015205 W KR2018015205 W KR 2018015205W WO 2019108049 A3 WO2019108049 A3 WO 2019108049A3
Authority
WO
WIPO (PCT)
Prior art keywords
skin
anticancer
regenerating
degrading
healing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2018/015205
Other languages
English (en)
Korean (ko)
Other versions
WO2019108049A2 (fr
Inventor
김광호
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kadesh Incoporation Ltd
Original Assignee
Kadesh Incoporation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020180086173A external-priority patent/KR101996383B1/ko
Priority claimed from KR1020180107032A external-priority patent/KR101963614B1/ko
Priority claimed from KR1020180107033A external-priority patent/KR101973198B1/ko
Priority claimed from KR1020180135373A external-priority patent/KR102022671B1/ko
Priority claimed from KR1020180152879A external-priority patent/KR102037431B1/ko
Application filed by Kadesh Incoporation Ltd filed Critical Kadesh Incoporation Ltd
Publication of WO2019108049A2 publication Critical patent/WO2019108049A2/fr
Publication of WO2019108049A3 publication Critical patent/WO2019108049A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition anticancéreuse antibactérienne de dégradation d'alcool, de cicatrisation de plaie cutanée ou de régénération cutanée, et une composition anti-asthmatique comprenant un mélange d'ions minéraux en tant que principe actif. Un mélange d'ions minéraux comprenant de la biotite, de la kaolinite, de la montmorillonite, de la serpentine, du mica, du clinochlore, de la vermiculite et de la muscovite peut inhiber la prolifération de la lignée cellulaire du cancer du sein humain MDA-MB -231, de la lignée cellulaire du cancer du foie humain HepG2, de la lignée cellulaire du cancer du poumon humain A549, de la lignée cellulaire du cancer du poumon humain A549, de la lignée cellulaire du cancer du sang humain HL60, de la lignée cellulaire du cancer de la peau humaine A375, de la lignée cellulaire du cancer du rein humain RCC4 (-), et de la lignée cellulaire du cancer du côlon humain HCT116, et peut donc être utile en tant que composition anticancéreuse; présente une excellente activité antibactérienne contre diverses bactéries; peut dégrader l'alcool avec une très grande efficacité, atténuant ainsi rapidement la gueule de bois, et est efficace pour améliorer les fonctions hépatiques lorsqu'elle est ingérée sur une longue période de temps; ne provoque pas d'irritation cutanée ni de cytotoxicité, est hautement stable chez l'être humain, et est efficace pour la cicatrisation des plaies cutanées et la régénération de la peau car elle agit pour former de nouveaux tissus au niveau d'une région de plaie et pour réduire les cicatrices; et joue un rôle dans la suppression ou l'élimination de divers symptômes asthmatiques dérivés de l'ovalbumine, restreint la prolifération de globules blancs, de neutrophiles et de lymphocytes dans le liquide de lavage broncho-alvéolaire (BALF) et le sérum, inhibe la prolifération des cellules épithéliales bronchiques, et réduit le mucus dans le bronchiole et l'infiltration de nombreuses cellules inflammatoires autour de la bronchiole et des vaisseaux en fonction de la dose. De plus, la composition a induit la réduction de la cytokine IL-4 liée aux cellules Th2. Par conséquent, une composition comprenant le mélange d'ions minéraux de la présente invention peut être utile en tant que composition pharmaceutique, cosmétique et alimentaire, étant donné qu'il s'agit d'un matériau naturel sans danger pour le corps humain et qui présente des effets anticancéreux, antibactériens, de dégradation d'alcool, de cicatrisation de plaie cutanée ou de régénération cutanée, et anti-asthmatiques.
PCT/KR2018/015205 2017-12-01 2018-12-03 Composition anticancéreuse, antibactérienne de dégradation d'alcool, de cicatrisation de plaie cutanée, de régénération cutanée ou anti-asthmatique comprenant un mélange d'ions minéraux Ceased WO2019108049A2 (fr)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
KR20170164585 2017-12-01
KR10-2017-0164585 2017-12-01
KR10-2018-0005734 2018-01-16
KR20180005734 2018-01-16
KR10-2018-0086173 2018-07-24
KR1020180086173A KR101996383B1 (ko) 2017-12-01 2018-07-24 퓨리톤을 유효성분으로 포함하는 항암용 조성물
KR1020180107032A KR101963614B1 (ko) 2018-09-07 2018-09-07 미네랄 이온 혼합물을 포함하는 알콜분해용 조성물
KR1020180107033A KR101973198B1 (ko) 2018-01-16 2018-09-07 미네랄 이온 혼합물을 포함하는 천식 예방 및 치료용 조성물
KR10-2018-0107032 2018-09-07
KR10-2018-0107033 2018-09-07
KR10-2018-0135373 2018-11-06
KR1020180135373A KR102022671B1 (ko) 2018-11-06 2018-11-06 미네랄 이온 혼합물을 포함하는 피부상처 치유 또는 피부재생용 조성물
KR1020180152879A KR102037431B1 (ko) 2018-11-30 2018-11-30 미네랄 이온 혼합물을 포함하는 항균용 조성물 및 이를 포함하는 항바이러스제
KR10-2018-0152879 2018-11-30

Publications (2)

Publication Number Publication Date
WO2019108049A2 WO2019108049A2 (fr) 2019-06-06
WO2019108049A3 true WO2019108049A3 (fr) 2019-08-08

Family

ID=66665149

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/015205 Ceased WO2019108049A2 (fr) 2017-12-01 2018-12-03 Composition anticancéreuse, antibactérienne de dégradation d'alcool, de cicatrisation de plaie cutanée, de régénération cutanée ou anti-asthmatique comprenant un mélange d'ions minéraux

Country Status (1)

Country Link
WO (1) WO2019108049A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112441825A (zh) * 2019-08-28 2021-03-05 延世大学原州产学合作团 用于缓解或改善炎症的陶瓷组合物及其制备方法
CN113952462B (zh) * 2021-11-18 2023-07-21 中南大学湘雅三医院 合成类纤维蛇纹石纳米材料的用途
US12171841B1 (en) 2024-07-19 2024-12-24 Imam Mohammad Ibn Saud Islamic University Synthesis and characterization of glauconite-based silicate nanorods as anticancer agent

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030225356A1 (en) * 2002-05-24 2003-12-04 Kulichikhin Valery G. Composition for cushions, wound dressings and other skin-contacting products
KR20090111642A (ko) * 2008-04-22 2009-10-27 순천향대학교 산학협력단 창상 치료용 미네랄 조성물
KR20100025435A (ko) * 2008-08-27 2010-03-09 순천향대학교 산학협력단 알레르기성 염증 억제 조성물
KR20120125372A (ko) * 2010-03-12 2012-11-14 이엘씨 매니지먼트 엘엘씨 생균 색조 화장품 조성물 및 방법
KR20170030245A (ko) * 2015-09-09 2017-03-17 이대훈 필로규산염광물을 이용한 천연미네랄 제조방법

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030225356A1 (en) * 2002-05-24 2003-12-04 Kulichikhin Valery G. Composition for cushions, wound dressings and other skin-contacting products
KR20090111642A (ko) * 2008-04-22 2009-10-27 순천향대학교 산학협력단 창상 치료용 미네랄 조성물
KR20100025435A (ko) * 2008-08-27 2010-03-09 순천향대학교 산학협력단 알레르기성 염증 억제 조성물
KR20120125372A (ko) * 2010-03-12 2012-11-14 이엘씨 매니지먼트 엘엘씨 생균 색조 화장품 조성물 및 방법
KR20170030245A (ko) * 2015-09-09 2017-03-17 이대훈 필로규산염광물을 이용한 천연미네랄 제조방법

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Virucidal test Antiviral, Virucidal Effect Test", VIRUCIDAL TEST PURITON, 23 April 2018 (2018-04-23), pages 1 - 13, Retrieved from the Internet <URL:http://puriton.kr/article> *
CHOI, RARA: "No Toxicity and No Preservative Natural Antibiotic 'PURITON' Getting Popularity", NEW MATERIAL, 18 September 2017 (2017-09-18), pages 1 - 2, Retrieved from the Internet <URL:http://www.koreadaily.com/news/read.asp?page=7&branch=LA&source=LA&category=economy&art_id=5615728> *
EXPERIMENT RESULT OF PURITON / CELL VIABILITY ASSAY, 23 June 2017 (2017-06-23), pages 1 - 6, XP055630092, Retrieved from the Internet <URL:http://puriton.kr/article//7/11/#none> *

Also Published As

Publication number Publication date
WO2019108049A2 (fr) 2019-06-06

Similar Documents

Publication Publication Date Title
EP4477658A3 (fr) Composition de liant aqueuse
WO2017194725A3 (fr) Composition de liant
MX2023010042A (es) Polinucleotidos moduladores.
WO2019032662A8 (fr) Agents de liaison à clec9a et utilisations associées
EP4272834A3 (fr) Utilisation thérapeutique de mitochondries et d&#39;agents mitochondriaux combinés
MX2021009295A (es) Composiciones de cannabidiol y usos de las mismas.
PE20191741A1 (es) Terapias combinadas dirigidas a pd-1, tim-3, y lag-3
WO2016011306A3 (fr) Modifications de terminal de polynucléotides
MY208384A (en) Pth prodrugs
EP3566750A3 (fr) Conjugués comprenant des agents de liaison cellulaire et des agents cytotoxiques
EP4417262A3 (fr) Polythérapie
MX2018015125A (es) Nuevos compuestos antibacterianos.
PH12019502363B1 (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
EP4516101A3 (fr) Compositions et utilisations de matériaux antimicrobiens présentant des propriétés compatibles avec les tissus
ZA202102702B (en) Synergistic disinfectant compositions having enhanced antimicrobial efficacy and stability, and methods of using the same
WO2016071503A8 (fr) Phagothérapie
WO2019108049A3 (fr) Composition anticancéreuse, antibactérienne de dégradation d&#39;alcool, de cicatrisation de plaie cutanée, de régénération cutanée ou anti-asthmatique comprenant un mélange d&#39;ions minéraux
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
WO2019108871A8 (fr) Revêtements résistant aux salissures biologiques et leurs procédés de fabrication et d&#39;utilisation
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
HK1245257A1 (zh) 具有广谱活性的抗菌化合物
MX2025003171A (es) Composiciones herbicidas
WO2016130581A3 (fr) Polythérapie anticancéreuse
MX2020013209A (es) Composiciones herbicidas.
PH12021550033A1 (en) Tumor reduction formulations and methods of use thereof

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18883605

Country of ref document: EP

Kind code of ref document: A2

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 01/02/2021)

122 Ep: pct application non-entry in european phase

Ref document number: 18883605

Country of ref document: EP

Kind code of ref document: A2